The aggressiveness of breast cancer correlates with proliferative capabilities as well as the vascularization of the tumour cells, which prompted us to determine the expression of Ki‐67 (proliferation marker) and CD31 (angiogenesis marker) in formalin‐fixed tumour tissues from control and the treatment groups using a double immunostaining strategy. The gene discussed is MKI67; the disease is breast cancer.